Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Line Development Market
The increase in the prevalence of cancer in low-income and middle-income countries is one of the major factors driving the cell line development market share. According to the International Agency of Cancer Research, in 2020, 9,503,710 new cancer cases were found in Asia. Aging, global warming, and unhealthy lifestyle lead to physiological changes triggering cancer. The cell line development plays an important role in development of therapeutic monoclonal antibodies and novel-antibody based therapies. Thus, rise in various types of cancer, acceptance of targeted therapies, and technological advancements in cell line development will upsurge the business growth.